Ipratropium Intranasal

Ipratropium Intranasal is a prescription medication used to treat the symptoms of seasonal allergies and runny nose caused by the common cold. 

• Ipratropium Intranasal is available under the following different brand names: Atrovent Nasal Spray

Common side effects of Ipratropium Intranasal include:

• Headache,
• Dry nose,
• Dry mouth or throat,
• Minor nosebleed,
• Sore throat,
• Blurred vision, and
• Unusual or unpleasant taste in the mouth

Serious side effects of Ipratropium Intranasal include:

• Blurred vision,
• Tunnel vision,
• Eye pay,
• Seeing halos around lights,
• Nosebleeds,
• Severe dry nose, and
• Painful or difficult urination

Rare side effects of Ipratropium Intranasal include:

• None 

Seek medical care or call 911 at once if you have the following serious side effects:

• Severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff muscles, high fever, profuse sweating, or tremors;
• Serious eye symptoms such as sudden vision loss, blurred vision, tunnel vision, eye pain or swelling, or seeing halos around lights;
• Serious heart symptoms include fast, irregular, or pounding heartbeats; fluttering in the chest; shortness of breath; sudden dizziness, lightheadedness, or passing out.

This is not a complete list of side effects and other serious side effects or health problems that may occur because of the use of this drug. Call your doctor for medical advice about serious side effects or adverse reactions. You may report side effects or health problems to FDA at 1-800-FDA-1088.

Adult and pediatric dosage

Nasal spray

• 0.03%
• 0.06%

Perennial Allergic/Nonallergic Rhinitis

Adult dosage

• Nasal spray (0.03%): 2 sprays (21 mcg/spray) per nostril every 8-12 hours; not to exceed 168-252 mcg/day.
• Seasonal allergic rhinitis: 2 sprays (0.06%) per nostril every 6 hours.

Pediatric dosage

• Below 6 years: Safety & efficacy not established.
• Above 6 years: 2 sprays (0.03%) per nostril every 8-12 hours.

Symptomatic relief of rhinorrhoea (Common Cold)

Adult dosage

• Nasal spray (0.06%): 2 sprays (0.42 mcg/spray) per nostril every 6 hours; no to exceed 672 mcg/day.

Pediatric dosage

• Below 5 years: Safety & efficacy not established.
• 5-12 years: 2 sprays (0.06%) in each nostril every 8 hours
• Above 12 years: 2 sprays (0.06%) in each nostril every 6-8 hours

Seasonal Allergic Rhinitis

Adult dosage

• Nasal spray (0.06%): 2 sprays (0.42 mcg/spray) per nostril every 6 hours; no to exceed 672 mcg/day.

Pediatric dosage

• Below 5 years: Safety & efficacy not established.
• Above 5 years: 2 sprays (0.06%) per nostril every 6 hours

Dosage Considerations – Should be Given as Follows: 

• See “Dosages”

If your medical doctor is using this medicine to treat your pain, your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with your doctor, health care provider, or pharmacist first.

• Ipratropium Intranasal has no noted severe interactions with any other drugs.
• Ipratropium Intranasal has no noted serious interactions with any other drugs.
• Ipratropium Intranasal has no noted moderate interactions with any other drugs.
• Ipratropium Intranasal has no noted minor interactions with any other drugs.

This information does not contain all possible interactions or adverse effects. Visit the RxList Drug Interaction Checker for any drug interactions. Therefore, before using this product, tell your doctor or pharmacist about all your products. Keep a list of all your medications with you and share this information with your doctor and pharmacist. Check with your healthcare professional or doctor for additional medical advice, health questions, or concerns.

Contraindications

• Hypersensitivity

Effects of drug abuse

• None

Short-Term Effects

• See “What Are Side Effects Associated with Using Ipratropium Intranasal?”

Long-Term Effects

• See “What Are Side Effects Associated with Using Ipratropium Intranasal?”

Cautions

• Use caution in patients with narrow-angle glaucoma, hepatic impairment, renal impairment, and BPH or bladder neck obstruction.
• Contact with the eye can cause burning.
• May cause dizziness, accommodation disorder, mydriasis, and blurred vision; caution patients about performing tasks requiring mental alertness, including operating heavy machinery.
• Immediate hypersensitivity reactions reported; discontinue use immediately if it occurs.

Pregnancy and Lactation

• May be acceptable during pregnancy.
• Lactation
  • Unknown whether distributed in breast milk.